{"name":"Kalypsys, Inc.","slug":"kalypsys-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"KD7040 Topical Gel","genericName":"KD7040 Topical Gel","slug":"kd7040-topical-gel","indication":"Actinic keratosis","status":"phase_2"}]}],"pipeline":[{"name":"KD7040 Topical Gel","genericName":"KD7040 Topical Gel","slug":"kd7040-topical-gel","phase":"phase_2","mechanism":"KD7040 Topical Gel is a topical gel formulation of a small molecule inhibitor.","indications":["Actinic keratosis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5BSUw2RENyQVZJck14bll1ZFlXSWdfVXNEN1NKY1MyOThrSVcxMUljNzhlenVrSmpWTE9manJERVMwRU92OXlrb29oYTZNc2c0dThiZ0Z6Y2VQOHk4a1hfV1F5OVA3bzZVM3ZEeExuZzBkb3VpLWg0a3ExQQ?oc=5","date":"2022-01-05","type":"pipeline","source":"Pharma Voice","summary":"Cross-functional teams: Models of success - Pharma Voice","headline":"Cross-functional teams: Models of success","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOQ3lEcHhUai00a2dORmFoWnB0YzMtUUlNVjBibzRQMl9NMlRUVGJDMlZxblhRMkRYVERCS3AyWDRQOXd0eTB1QjZjTzhDUUZmU0d3X3dIYjUtcWZEeFNHaUZkaW5lSWFwZHQtMmhPM3gxZ0N6MU04RlBlLUJ0bE9ObzdXaGpQRjVlSHZHWmhRTTRYRTI5Q2N5VlRIYkFJN3pVTENwcEtBMWxNdWs?oc=5","date":"2012-08-01","type":"pipeline","source":"National Human Genome Research Institute (NHGRI) (.gov)","summary":"NIH Launches First Center In Nationwide Chemical Genomics Network - National Human Genome Research Institute (NHGRI) (.gov)","headline":"NIH Launches First Center In Nationwide Chemical Genomics Network - National Human Genome Research Institute (NHGRI) (.g","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE02Smw2Sm1NYk04dG1EN3JvczhwbVNSb3Itc2d5dDZuQW91X2JSeDFlajVMVEN3R2M4ZWt4dEplN2RzcDZuZlF1NjlkMXZLZ2IzbWVlOWtmRmR5aFVVZDRQS25La05UbzRU?oc=5","date":"2006-08-28","type":"pipeline","source":"C&EN","summary":"Speedy Discovery - C&EN","headline":"Speedy Discovery - C&EN","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}